GenScript cPass SARS-CoV-2 Neutralization Antibody Detection Kit Instructions for Use

cPass SARS-CoV-2 Neutralization Antibody Detection Kit is an in vitro diagnostic test kit manufactured by GenScript for the detection of SARS-CoV-2 neutralization antibody.


GenScript cPass SARS-CoV-2 Neutralization Antibody Detection Kit Instructions for Use - cover page
Brand
GenScript
Category
Health Care
Document type
User Manual
Language
English
Pages
50
File format
PDF
File size
1.3 MB
Published
26 October, 2023
Updated
26 October, 2023
MD5 checksum
A0DD46E3B46010304003AA3E1DE0F9F7

About this manual

This document provides detailed instructions for using the cPass SARS-CoV-2 Neutralization Antibody Detection Kit, a blocking ELISA designed to detect total neutralizing antibodies to SARS-CoV-2 in human serum and plasma. The kit is intended for use in certified laboratories under FDA Emergency Use Authorization and is not for diagnosing acute infection. Results indicate the presence of neutralizing antibodies but do not confirm immunity or protection from infection.

The kit includes pre-coated plates, controls, and reagents for performing the assay. It uses purified hACE2 protein and HRP-conjugated RBD to detect antibodies that block the RBD-hACE2 interaction. The test is semi-quantitative and requires specific handling and storage conditions to ensure accurate results.

What's inside

  • INTENDED USE
  • BACKGROUND
  • ASSAY PRINCIPLE
  • KIT CONTENTS
  • STORAGE
  • WARNINGS
  • PRECAUTIONS
  • REAGENTS/EQUIPMENT NEEDED BUT NOT SUPPLIED
  • SPECIMEN COLLECTION AND STORAGE
  • SEMI-QUANTITATIVE PROTOCOL

Frequently asked questions

What is the purpose of this kit?

The cPass SARS-CoV-2 Neutralization Antibody Detection Kit is intended for the qualitative and semi-quantitative direct detection of total neutralizing antibodies to SARS-CoV-2 in human serum and dipotassium EDTA plasma.

Is this kit for diagnosing acute SARS-CoV-2 infection?

No, the kit should not be used to diagnose or exclude acute SARS-CoV-2 infection.

What is the assay principle?

The kit is a blocking ELISA that detects functional immunoglobulins neutralizing the interaction between RBD and hACE2.

What are the storage conditions?

The unopened kit is stable at 2°C to 8°C until expiration date and the opened kit is stable for up to 1 month from the date of opening at 2°C to 8°C.

Download PDF (1.3 MB)

More GenScript Manuals


View all GenScript manuals →